- Home
- RDZN vs ORMP Comparison
RDZN vs ORMP Comparison
Compare RDZN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDZN | ORMP |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | 308 | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4M | 165.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | RDZN | ORMP |
|---|---|---|
| Price | $1.71 | $3.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 618.3K | 218.5K |
| Earning Date | 02-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $33.77 | N/A |
| Revenue Next Year | $51.46 | N/A |
| P/E Ratio | ★ N/A | $4.19 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $0.81 | $1.98 |
| 52 Week High | $2.56 | $5.01 |
Technical Indicators
Market Signals| Indicator | RDZN | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 40.99 |
| Support Level | $1.60 | $3.21 |
| Resistance Level | $1.99 | $3.80 |
| Average True Range (ATR) | 0.14 | 0.27 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 8.82 | 9.91 |
Price Performance
Historical ComparisonAbout RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.